The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
Cadence Design Systems CDNS
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Cadence Design Systems, Inc.
read at $326.24
Cadence Design Systems holds its Distribution at $326.24.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 266 days |
| Price | $326.24 |
| Valuation | 75.87 trailing · 34.69 forward price to earnings |
| Values screen | PASS · score 76.6 |
| Beta | 1.15 |
The opportunity · what the numbers say it is worth
Our framework reads OVERVALUED — it trades above our $322.24 fair value estimate, strong competitive moat, 18.70% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 18.70% |
| Profit margin | 21.18% |
| Debt to equity | 46.99 |
| Analyst consensus | Strong Buy · 26 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 25.8% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 34.4% of assets, under the 49% limit. Pass
- Revenue purity Only 1.9% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Premium chip tools trade above fair value
Engineers building the next wave of AI chips depend on Cadence software every day to verify designs before they reach silicon. The business shows real strength, with 19% revenue growth, 21% profit margins and a strong moat that keeps competitors at bay, yet the shares sit 2% above our fair value at a forward multiple of 35 times.
We pass because the price already bakes in the strong buy ratings from 26 analysts and their 400 dollar median target. Growth and returns on equity look solid, but paying a premium leaves investors exposed if growth slows even modestly or if broader tech spending pulls back.
Currency moves and customer concentration in semiconductors add further volatility on top of the stretched valuation. Analysis, not advice.
| Forward P/E | 34.7x priced for continued growth |
| Trailing P/E | 75.9x expensive — the price assumes strong growth ahead |
| Revenue growth | 18.7% steady growth |
| Profit margin | 21.2% healthy profit margins |
| Return on equity | 20.7% an exceptional return on shareholder capital |
| Debt to equity | 0.47 minimal debt — a conservative balance sheet |
| Current ratio | 1.47 adequate liquidity, worth monitoring |
| Beta | 1.15 moves a little more than the market |
| Market cap | $90.0B |
| Employees | 15,110 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on CDNS
- › Cadence Design Systems, Domo, and PubMatic Shares Plummet, What You Need To Know StockStory · 15d ago
- › Chip Stocks Enter Bear Market. Astera Labs Continues Slump. Investor's Business Daily · 15d ago
- › S&P 500 Posts Weekly Decline Amid Worries Over Artificial Intelligence, Middle East MT Newswires · 15d ago
- › Cadence & Synopsys slide as Kimi K3 designs chip in 48h using no proprietary EDA Investing.com · 15d ago
- › Top Midday Stories: Netflix Q2 Revenue, Q3 Guidance Miss Estimates; SpaceX Aborts Launch, Shares Tumble MT Newswires · 15d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in CDNS's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
CDNS trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 12.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (26 analysts) rates it strong buy, with a mean price target of $380.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | SCANNELL PAUL | Officer | 1,071 | $369,559 | |
| 2026-05-18 | SCANNELL PAUL | Officer | 1,071 | $369,559 | |
| 2026-05-07 | PLUMMER JAMES D | Director | 779 | · | |
| 2026-05-07 | ADAMS MARK W | Director | 779 | · | |
| 2026-05-07 | LIUSON JULIA | Director | 714 | · | |
| 2026-05-07 | VAN DEN HOVE LUC | Director | 714 | · | |
| 2026-05-07 | GAVRIELOV MOSHE NACHUM | Director | 714 | · | |
| 2026-05-07 | PLUMMER JAMES D | Director | 714 | · | |
| 2026-05-07 | BRENNAN ITA M | Director | 714 | · | |
| 2026-05-07 | KRAKAUER MARY LOUISE | Director | 714 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $364.20 | +5.6% | · | $1,056 | +5.6% |
| 2 months | $265.66 | +44.8% | · | $1,448 | +44.8% |
| 3 months | $290.32 | +32.5% | · | $1,325 | +32.5% |
| 6 months | $335.43 | +14.6% | · | $1,146 | +14.6% |
| 1 year | $305.69 | +25.8% | · | $1,258 | +25.8% |
| 2 years | $296.18 | +29.8% | · | $1,298 | +29.8% |
| 3 years | $229.30 | +67.7% | · | $1,677 | +67.7% |
| 5 years | $129.28 | +197.5% | · | $2,975 | +197.5% |
Historical returns from market close data. Past performance does not guarantee future results.